|
|
Issue
|
Alert me when new journal issues are available via or via  |
|
|
| Transplantation Proceedings |
| Volume 35, Issue 3, Supplement (May 2003) |
|
Search Within This Issue
|
|
|
|
|
|
|
Editorial
|
|
Dear Colleague:
Barry D. Kahan
page ix
Full Text |
Full-Text PDF (35 KB)
|
|
Dedication
|
|
Tribute to Suren Sehgal
Joseph Camardo
pages S2-S4
Full Text |
Full-Text PDF (137 KB)
|
|
Discovery, development, and delivery of sirolimus
|
|
Sirolimus: its discovery, biological properties, and mechanism of action
S.N Sehgal
pages S7-S14
Abstract |
Full Text |
Full-Text PDF (289 KB)
|
|
The development of immunosuppression: the rapamycin milestone
R.Y. Calne
pages S15-S17
Full Text |
Full-Text PDF (57 KB)
|
|
The Rapamune era of immunosuppression 2003: the journey from the laboratory to clinical transplantation
J Camardo
pages S18-S24
Abstract |
Full Text |
Full-Text PDF (115 KB)
|
|
Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience
B.D Kahan, R Knight, L Schoenberg, J Pobielski, R.H Kerman, K Mahalati, Y Yakupoglu, F.T Aki, S Katz, C.T Van Buren
pages S25-S34
Full Text |
Full-Text PDF (933 KB)
|
|
Renal transplantation
|
|
Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation
B.D Kahan
pages S37-S51
Abstract |
Full Text |
Full-Text PDF (562 KB)
|
|
Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience
E Morelon, H Kreis
pages S52-S57
Full Text |
Full-Text PDF (228 KB)
|
|
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the sirolimus European renal transplant study
B Charpentier, Sirolimus European Renal Transplant Study, C.G Groth, L Bäckman, J.-M Morales, R Calne, H Kreis, P Lang, J.-L Touraine, K Claesson, J.M Campistol, D Durand, L Wramner, C Brattström)
pages S58-S61
Abstract |
Full Text |
Full-Text PDF (69 KB)
|
|
Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine
C Ponticelli, A Tarantino, A Aroldi, V Sparacino, S Stefoni, F Citterio, L Duca, M.P Scolari, S Calabrese, P Altieri, G Civati, B Cesana
pages S62-S63
Abstract |
Full Text |
Full-Text PDF (51 KB)
|
|
Delivery of sirolimus
|
|
Optimizing the long-term outcome of renal transplants: opportunities created by sirolimus
J.R Chapman
pages S67-S72
Abstract |
Full Text |
Full-Text PDF (109 KB)
|
|
Use of sirolimus to facilitate cyclosporine avoidance or steroid withdrawal in kidney transplant recipients
D.E Hricik
pages S73-S78
Abstract |
Full Text |
Full-Text PDF (105 KB)
|
|
How should sirolimus be used in clinical practice?
R.W.G Johnson
pages S79-S83
Full Text |
Full-Text PDF (136 KB)
|
|
Sirolimus experience at a Swedish transplantation center
H.E Wilczek, C Brattström
pages S84-S88
Abstract |
Full Text |
Full-Text PDF (71 KB)
|
|
Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients—a single center experience
R El-Sabrout, V Delaney, M Qadir, F Butt, P Hanson, K.M.H Butt
pages S89-S94
Full Text |
Full-Text PDF (120 KB)
|
|
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation
R.N Formica, K.M Lorber, A.L Friedman, M.J Bia, F Lakkis, J.D Smith, M.I Lorber
pages S95-S98
Abstract |
Full Text |
Full-Text PDF (66 KB)
|
|
Sirolimus: a single center experience in combination with calcineurin inhibitors
R Masterson, M Leikis, V Perkovic, K Nicholls, R Walker
pages S99-S104
Abstract |
Full Text |
Full-Text PDF (126 KB)
|
|
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients
A Lo, M.F Egidi, L.W Gaber, A.O Gaber
pages S105-S108
Abstract |
Full Text |
Full-Text PDF (69 KB)
|
|
Sirolimus immunotherapy: the Albany Medical Center experience
F.S Escobar, A.L Isenberg, D.J Conti
pages S109-S112
Abstract |
Full Text |
Full-Text PDF (77 KB)
|
|
Sirolimus in pediatric transplant recipients
R Sindhi
pages S113-S114
Abstract |
Full Text |
Full-Text PDF (52 KB)
|
|
Reduced and standard target concentration tacrolimus with sirolimus in renal allograft recipients
G.R Russ, S Campbell, S Chadban, J Eris, P O’Connell, B Pussell, R Walker, For the Australian Rapamune–Tacrolimus Study Group
pages S115-S117
Abstract |
Full Text |
Full-Text PDF (60 KB)
|
|
Minimizing calcineurin inhibitor drugs in renal transplantation
S.M Flechner
pages S118-S121
Abstract |
Full Text |
Full-Text PDF (70 KB)
|
|
Fixed-dose sirolimus with reduced dose calcineurin inhibitor: the University of Colorado experience
A.C Wiseman, I Kam, U Christians, A Jani, T Bak, M Wachs, L Chan
pages S122-S124
Full Text |
Full-Text PDF (58 KB)
|
|
Kidney transplantation without calcineurin inhibitors using sirolimus
M.D Stegall, T.S Larson, M Prieto, J Gloor, S Textor, S Nyberg, S Sterioff, M Ishitani, M Griffin, W Kremers, W Lund, T Schwab, F Cosio, J Velosa
pages S125-S127
Abstract |
Full Text |
Full-Text PDF (59 KB)
|
|
Sirolimus monotherapy following Campath-1H induction
V Rao, J.D Pirsch, B.N Becker, S.J Knechtle
pages S128-S130
Abstract |
Full Text |
Full-Text PDF (65 KB)
|
|
Conversion to sirolimus in solid organ transplantation: a Single-Center experience
M.F Egidi, P.A Cowan, A Naseer, A.O Gaber
pages S131-S137
Abstract |
Full Text |
Full-Text PDF (118 KB)
|
|
Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a Single-Center experience
D.R.J Kuypers, A Herelixka, Y Vanrenterghem, Leuven Collaborative Group for Renal Transplantation
pages S138-S142
Abstract |
Full Text |
Full-Text PDF (71 KB)
|
|
Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients
J.D Morrisett, G Abdel-Fattah, B.D Kahan
pages S143-S150
Abstract |
Full Text |
Full-Text PDF (168 KB)
|
|
Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation
C Legendre, J.M Campistol, J.-P Squifflet, J.T Burke, Sirolimus European Renal Transplant Study Group
pages S151-S153
Abstract |
Full Text |
Full-Text PDF (83 KB)
|
|
Tubular function in patients with hypokalemia induced by sirolimus after renal transplantation
J.M Morales, A Andrés, B Dominguez-Gil, M.P Sierra, J Arenas, M Delgado, M.C Casal, L Rodicio
pages S154-S156
Full Text |
Full-Text PDF (58 KB)
|
|
Therapeutic monitoring of sirolimus: its contribution to optimal prescription
D.W Holt, K Denny, T.D Lee, A Johnston
pages S157-S161
Abstract |
Full Text |
Full-Text PDF (87 KB)
|
|
Cardiac transplantation and disease
|
|
Use of rapamycin-impregnated stents in coronary arteries
J.E Sousa, A.G.M.R Sousa, M.A Costa, A.C Abizaid, F Feres
pages S165-S170
Abstract |
Full Text |
Full-Text PDF (263 KB)
|
|
Sirolimus therapy in cardiac transplantation
B Radovancevic, B Vrtovec
pages S171-S176
Abstract |
Full Text |
Full-Text PDF (185 KB)
|
|
Safety and efficacy of sirolimus in kidney transplant patients and in patients with coronary artery disease undergoing angioplasty
H Tedesco Silva, C.R Felipe, P.G.P Machado, R Garcia, S Motegi, B.H Hosaka, N.M Hanzawa, S.I Park, D Casarini, V.C Lima, M Franco, J.O Medina-Pestana
pages S177-S180
Abstract |
Full Text |
Full-Text PDF (69 KB)
|
|
Liver transplantation
|
|
De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco
F. Vincenti, P. Stock
pages S183-S186
Abstract |
Full Text |
Full-Text PDF (65 KB)
|
|
Pancreas and islet transplantation
|
|
Sirolimus and islet transplants
B.J. Hering, M. Wijkstrom
pages S187-S190
Full Text |
Full-Text PDF (72 KB)
|
|
Liver transplantation
|
|
Sirolimus in liver transplantation
J.F Trotter
pages S193-S200
Abstract |
Full Text |
Full-Text PDF (123 KB)
|
|
Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation
A.S MacDonald
pages S201-S208
Abstract |
Full Text |
Full-Text PDF (930 KB)
|
|
Ten years of sirolimus therapy in orthotopic liver transplant recipients
G.W Neff, M Montalbano, A.G Tzakis
pages S209-S216
Abstract |
Full Text |
Full-Text PDF (571 KB)
|
|
Preclinical aspects
|
|
Preclinical results of sirolimus treatment in transplant models
S.M Stepkowski
pages S219-S226
Abstract |
Full Text |
Full-Text PDF (299 KB)
|
|
Molecular actions of sirolimus: sirolimus and mTor
R.A Kirken, Y.L Wang
pages S227-S230
Abstract |
Full Text |
Full-Text PDF (98 KB)
|
|
Rapamycin: signaling in vascular smooth muscle
A.R Marks
pages S231-S233
Abstract |
Full Text |
Full-Text PDF (182 KB)
|
|
CME—quiz
pages S235-S240
Full-Text PDF (331 KB)
|
|
Evaluation
page S241
Full-Text PDF (47 KB)
|
|
|
|